MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Articles Found

Page: « Previous 1 2 3 4 5 6 7 8 9 10 ... Next »



 Recent Articles   Industry   Published  New Window
The Lake Norman Chamber of Commerce Recognizes Huntersville Physician Dr. John Powderly Pharma/BioTech/Nutrition 2019/01/25 More
STEMCELL Technologies Launches mTeSR™ Plus - A Next-Generation Culture System for Human ES and iPS Cell Maintenance Pharma/BioTech/Nutrition 2019/01/23 More
Sartorius Stedim Biotech Launches Services for Characterization of New Biological Entities (NBE) Pharma/BioTech/Nutrition 2019/01/23 More
Sartorius Stedim Biotech Introduces BIOSTAT® RM TX with Flexsafe® RM TX for Producing Consistent Quality Cellular Products Pharma/BioTech/Nutrition 2019/01/21 More
Sartorius to Demonstrate Special Data Analysis At Night of Knowledge Event Series Pharma/BioTech/Nutrition 2019/01/18 More
FDA Accepts Genentech’s Supplemental Biologics License Application for Tecentriq Plus Chemotherapy (Abraxane and Carboplatin) Pharma/BioTech/Nutrition 2019/01/17 More
Cell Therapy Market to Grow Beyond Oncology As Big Pharma Expands Investments Finds Frost & Sullivan Pharma/BioTech/Nutrition 2019/01/17 More
Bioquark, Inc. and Ectocrine Technologies, LLC to Collaborate on Mosquito-Derived Health Products Pharma/BioTech/Nutrition 2019/01/10 More
BTG and OMNY Partner to Improve Treatment of Snake Bite Victims Pharma/BioTech/Nutrition 2019/01/09 More
FDA Approves Genentech’s Tecentriq in Combination with Avastin and Chemotherapy Pharma/BioTech/Nutrition 2019/01/07 More
Exelixis and Ipsen Initiate Phase 3 Pivotal Trial of Cabozantinib in Combination with Atezolizumab Versus Sorafenib Pharma/BioTech/Nutrition 2018/12/05 More
Ipsen and 3BP Announce First Patient Dosed in Phase I/II study for First-in-Class Radionuclide (IPN01087) Pharma/BioTech/Nutrition 2018/11/20 More
EC Approves Ipsen’s Cabometyx® (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib Pharma/BioTech/Nutrition 2018/11/15 More
Neurent Medical's RF-based Minimally Invasive Rhinitis Therapy Earns Acclaim from Frost & Sullivan Pharma/BioTech/Nutrition 2018/11/13 More
Market Entrants Offering Digitized Mass Spectrometry Solutions Gain a Competitive Edge over Traditional Vendors Finds Frost & Sullivan Pharma/BioTech/Nutrition 2018/11/06 More




Page: « Previous 1 2 3 4 5 6 7 8 9 10 ... Next »

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Inkwood Research

Visit  Limelon Advertising, Co.





 
  ©2019 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)